CARMEN KOSICEK: Open Payments
NPI 1255863767 · HILLSBORO, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,931 in 79 payments from 13 companies in 2025. Trend: 2023 $56,716 · 2024 $4,554 · 2025 $4,931
Food & beverage: $3,320Consulting: $1,540Education: $71
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $2,006 |
| Teva Pharmaceuticals USA, Inc. | 8 | $646 |
| ABBVIE INC. | 16 | $516 |
| Axsome Therapeutics, Inc. | 14 | $444 |
| Janssen Scientific Affairs, LLC | 4 | $405 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $242 |
| Tris Pharma Inc | 5 | $202 |
| Alkermes, Inc. | 3 | $154 |
| Biogen, Inc. | 1 | $82 |
| Janssen Pharmaceuticals, Inc | 4 | $80 |
Products named: COBENFY, SPRAVATO, Auvelity, VRAYLAR, AUSTEDO XR, UZEDY, CAPLYTA, VIVITROL.
Industry payments across OR — which companies pay providers there.
